3 terminated, 2 active not recruiting, 2 recruiting, 1 not yet recruiting. 4 Phase 2, 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 2, Recruiting 1, Terminated 1 |
| Not applicable | 3 | Not yet recruiting 1, Recruiting 1, Terminated 1 |
Follow Thyroid Gland Papillary Carcinoma: new trials by email Literature Review of Thyroid Gland Papillary Carcinoma trials Research Report on Thyroid Gland Papillary Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial Internet-Based Intervention, Interview, Questionnaire Administration - Differentiated Thyroid Gland Carcinoma, Malignant Testicular Neoplasm | Not applicable | Not yet recruiting | University of Michigan Rogel Cancer Center | 142 | 2026-12-01 | 2026-10-15 |
| Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors Counseling, Interview, Questionnaire Administration - Thyroid Gland Follicular Carcinoma, Thyroid Gland Papillary Carcinoma | Not applicable | Recruiting | Mayo Clinic | 20 | 2026-06-23 | 2026-07-08 |
| Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation Biospecimen Collection, Cobimetinib, Computed Tomography - Thyroid Gland Follicular Carcinoma, Thyroid Gland Oncocytic Carcinoma | Phase 2 | Recruiting | City of Hope Medical Center | 21 | 2024-07-15 | 2026-02-02 |
| Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule Quality-of-Life Assessment, Radiofrequency Ablation - Benign Thyroid Gland Neoplasm, Recurrent Thyroid Gland Carcinoma | Not applicable | Terminated | M.D. Anderson Cancer Center | 1 | 2022-08-29 | 2025-04-02 |
| Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer Computed Tomography, Fluorine F 18 Tetrafluoroborate, Positron Emission Tomography - Differentiated Thyroid Gland Carcinoma, Thyroid Gland Follicular Carcinoma | Terminated | Mayo Clinic | 11 | 2022-04-22 | 2026-09-24 | |
| Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer Quality-of-Life Assessment, Questionnaire Administration, Selpercatinib - Malignant Thyroid Gland Neoplasm, Poorly Differentiated Thyroid Gland Carcinoma | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 30 | 2021-02-26 | 2026-05-20 |
| Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer Biospecimen Collection, Cabozantinib S-malate, Computed Tomography - Differentiated Thyroid Gland Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 11 | 2020-02-10 | 2026-07-31 |
| Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer Lenvatinib - Differentiated Thyroid Gland Carcinoma, Thyroid Gland Follicular Carcinoma | Phase 2 | Terminated | Emory University | 4 | 2019-01-16 | 2022-11-10 |
Thyroid Cancer, Papillary (8) · Adenocarcinoma, Follicular (6) · Thyroid Neoplasms (3) · Carcinoma, Medullary (1) · Melanoma (1) · Testicular Neoplasms (1) · Thyroid Carcinoma, Anaplastic (1) · Thyroid Nodule (1)
Adenocarcinoma (8) · Adenocarcinoma, Papillary (8) · Carcinoma (8) · Endocrine Gland Neoplasms (8) · Endocrine System Diseases (8) · Head and Neck Neoplasms (8) · Neoplasms (8) · Neoplasms by Histologic Type (8) · Neoplasms by Site (8) · Neoplasms, Glandular and Epithelial (8) · Thyroid Diseases (8) · Thyroid Neoplasms (5) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2)
Magnetic Resonance Spectroscopy (3) · Interviews as Topic (2) · Specimen Handling (2) · CTLA-4 Antigen (1) · Counseling (1) · Glycoprotein Hormones, alpha Subunit (1) · High-Energy Shock Waves (1) · Iodine-131 (1) · Ipilimumab (1) · Nivolumab (1) · Radiofrequency Ablation (1) · Thyrotropin Alfa (1) · Vemurafenib (1) · X-Rays (1) · cabozantinib (1)
M.D. Anderson Cancer Center (2) · Mayo Clinic (2) · City of Hope Medical Center (1) · Emory University (1) · National Cancer Institute (NCI) (1) · University of Michigan Rogel Cancer Center (1)
United States (8)
Abd Moain Abu Dabrh, MB, BCh, MS (1) · Bhavana Konda (1) · Kim O Learned (1) · Mark Zafereo (1) · Megan R Haymart, MD (1) · Sasan Fazeli (1) · Stephen M. Broski, M.D. (1) · Taofeek K. Owonikoko, MD, PhD (1)
P30CA033572 (1), R34CA286602 (1), UM1CA186712 (1)